GENE DEFECTS OF BAND 11Q23 IN HEMATOLOGIC MALIGNANCIES

Information

  • Research Project
  • 3196333
  • ApplicationId
    3196333
  • Core Project Number
    R01CA051664
  • Full Project Number
    5R01CA051664-02
  • Serial Number
    51664
  • FOA Number
  • Sub Project Id
  • Project Start Date
    12/1/1989 - 34 years ago
  • Project End Date
    11/30/1994 - 29 years ago
  • Program Officer Name
  • Budget Start Date
    12/1/1990 - 33 years ago
  • Budget End Date
    11/30/1991 - 32 years ago
  • Fiscal Year
    1991
  • Support Year
    2
  • Suffix
  • Award Notice Date
    11/29/1990 - 33 years ago
Organizations

GENE DEFECTS OF BAND 11Q23 IN HEMATOLOGIC MALIGNANCIES

Twelve genes in the 11q23q25 band region of chromosome 11 were found amplified in a patient with acute myelogenous leukemia. They include five genes important in T-cell receptor and antigen recognition (CD3 epsilon, delta and gamma, N-CAM and Thy-1) and the proto-oncogene ets-1. The order of genes in this region was determined using pulse field electrophoresis and Southern blots of somatic cell hybrids, each containing a single human derivative chromosome having an 11q23 breakpoint from six different chromosomal defects. A common breakpoint region was found between the 11q23.3 CD3 gamma and ets-1 genes in four recurrent genomic rearrangements found in acute monocytic (AMoL) and myelomonocytic leukemia (AMMoL), acute lymphocytic leukemia (ALL) and B-cell diffuse lymphoma, using somatic cell hybrids. Utilizing a lambda genomic library of a B-cell lymphoma cell line with a t(11;14) (q23.3;q32.3), we have found evidence that the IgH gene C gamma 2 of chromosome 14 is rearranged with chromosome 11 specific DNA. The involvement of the 14q32.3-IgH region, which has been the subject of extensive molecular analysis, should facilitate the cloning and sequencing of a putative oncogene involved in the 11q23.3 breakpoint. This would aid in determining whether the same or a different region of the putative oncogene is involved in similar translocations found in other patients with diffuse lymphoma. Transcription and exon sequences of the gene in question will be studied by Northern blot analysis and cDNA libraries. Selected cDNA clones will be used to map introns and exons of the genomic clones and define the boundary of the gene S1 nuclease digestion. Probes generated from genomic and cDNA libraries from t(11;14) positive diffuse lymphoma will be used in Southern and Northern blots to find out whether the 11q23.3 gene is involved in any of 15 additional recurrent rearrangements of band 11q23 (with a chromosome other than 14) found in subgroups of All, CLL, AMoL, AMMoL and preleukemia. If the same putative 11q23 oncogene is involved, somatic cell hybrids from a t(4;11) (q21;q23.3) from two patients with ALL, a t(9;11) (p.22:q23.3) from one patient with AMoL, an inv ins(X;11) (q24;q23q21) from a patient with AMMoL and a CLL del(11) (q14q23), will be used to construct genomic libraries to characterize, in the reciprocal chromosome breakpoint 4q21, 9p22, Xq24 and 11q14, genes that may help explain the different cell phenotypes observed, since such genes may play a role in stem cell differentiation toward pre-B, B, monocytic or myelomonocytic cell lineage.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R01
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    396
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
  • Funding Mechanism
  • Study Section
    PTHB
  • Study Section Name
    Pathology B Study Section
  • Organization Name
    HAHNEMANN UNIVERSITY
  • Organization Department
  • Organization DUNS
  • Organization City
    PHILADELPHIA
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    19129
  • Organization District
    UNITED STATES